OYSTER POINT PHARMA INC (OYST)

US69242L1061 - Common Stock

11.17  +0.02 (+0.18%)

After market: 11.17 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
19.58M24.54M0.000.000.00
Cost Of Goods
4.52M1.52MN/AN/AN/A
Gross Profit
15.06M23.01MN/AN/AN/A
Operating Expenses
173.52M119.67M70.99M47.30M16.74M
Research and Development
18.72M24.23M39.81M33.63M13.76M
Selling, General, and Administrative Expenses
154.80M95.44M31.18M13.67M2.98M
Operating Income
-158.45M-96.66M-70.99M-47.30M-16.74M
Interest Income/Expense
-12.33M-3.73M470.00K1.59M230.00K
Other Income/Expense
-5.87M-270.00KN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
-176.65M-100.66M-70.52M-45.71M-16.50M
Net Income
-176.65M-100.66M-70.52M-45.71M-16.50M
EBITDA
-158.14M-96.51M-70.91M-47.28MN/A
 
Per Share Data
EPS Diluted Total Ops
-6.64-3.87-2.92-2.14-0.80
Non GAAP EPS
-6.65-3.87-2.92N/AN/A
 
Statistics
Gross Profit Margin
76.93%93.79%N/AN/AN/A
Profit Margin
-901.99%-410.20%N/AN/AN/A
Operating Profit Margin
-809.09%-393.88%N/AN/AN/A

All data in USD

Charts